| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/24/1999 | EP0662836B1 Germicidal detergent-iodine compositions having reduced detergent content |
| 11/24/1999 | EP0650366B1 Compositions and methods for treating wounds |
| 11/24/1999 | CN2350061Y Operative wound bandage |
| 11/24/1999 | CN2350057Y Acupoint medicine patch |
| 11/24/1999 | CN1236435A A dissolution test method for solid steroidal pharmaceutical formulations |
| 11/24/1999 | CN1236323A Administrable compositions nd method for magnetic resonance imaging |
| 11/24/1999 | CN1236318A Method for treating bronchitis with uridine triphosphates and related compounds |
| 11/24/1999 | CN1236317A Stable aspirin ointment preparations |
| 11/24/1999 | CN1236316A Stable aspirin-containing preparations for external use |
| 11/24/1999 | CN1235996A Coating bituminous substrates |
| 11/24/1999 | CN1235866A Method for microencapsulating solid substance |
| 11/24/1999 | CN1235846A Medicine preparation administrated through nasal mucosa |
| 11/24/1999 | CN1235842A Bone bi-syndrome paste |
| 11/24/1999 | CN1235841A Method for preparing Bazhen sugarless powder |
| 11/24/1999 | CN1235837A Psoriasis paster |
| 11/24/1999 | CN1235836A Pear syrup for nourishing lungs |
| 11/24/1999 | CN1235833A Novel drug composition for treating and curing and its preparing method |
| 11/24/1999 | CN1235829A Composite containing vitamin B12 |
| 11/24/1999 | CN1235827A Estradiol benzoate gel agent and its preparing method |
| 11/24/1999 | CN1235825A Sustained release capsule and formulations |
| 11/24/1999 | CN1235824A Process for producing enteric coated pancreatin granules |
| 11/24/1999 | CN1235795A Anti-cellulite pantyhose |
| 11/24/1999 | CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity |
| 11/24/1999 | CN1046632C Method for preparing injectable preparation containing cephalosporin medicament |
| 11/24/1999 | CN1046622C Pulverulent mannitol of moderate friability and process for its preparation and use thereof |
| 11/23/1999 | US5990297 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 11/23/1999 | US5990287 Immunoglobulin which binds to surface antigen of stomach cancer cell mnk45 and colon cancer cell c-1; for diagnosis of cancer; for anticarcinogenic agents and immunotoxins |
| 11/23/1999 | US5990194 Biodegradable in-situ forming implants and methods of producing the same |
| 11/23/1999 | US5990183 Preparing a secondary emulsion by dispersing a primary emulsion containiing a solidifying component in a second continuous phase as a second dispersion phase; solidifying; removing the first dispersion phase |
| 11/23/1999 | US5990179 An anodic donor reservoir comprising of the acid addition salt of a base therapeutic agent wherein the ph of said solution has been adjusted to within a predetermined range and the water content is aat least about 44.3%; transdermal drug |
| 11/23/1999 | US5990176 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 11/23/1999 | US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders |
| 11/23/1999 | US5990166 Compounds and compositions for delivering active agents |
| 11/23/1999 | US5990162 Method for treatment of fibromyalgia and chronic fatigue syndrome |
| 11/23/1999 | US5990153 Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury |
| 11/23/1999 | US5990152 Acid resistant to gastric juice; rapidly dissolves in the duodenum; group 1a and 2a metal salts; ammonium and amine salts; storage stability |
| 11/23/1999 | US5990141 Administering 5-methyl-isoxazole-4-carboxylic acid-n-(4-trifluoromethyl)anilide or 2-cyano-3-hydroxy-n-(4-trifluoro-methyl)phenyl-2-butenamide; antitumor,-carcinogenic and proliferative agents; kinase inhibitors |
| 11/23/1999 | US5990134 Orally administering droperidol to the migraine patient, in an amount from 0.5 mg to about 20 mg |
| 11/23/1999 | US5990100 Composition and method for treatment of psoriasis |
| 11/23/1999 | US5990096 Formulations containing hyaluronic acid |
| 11/23/1999 | US5990095 Use of hyaluronic acid and forms to prevent arterial restenosis |
| 11/23/1999 | US5990089 Introducing a polynucleotide into a eukaryotic cell in a living animal comprising contacting the cell with a composition comprising a polynucleotide and a dendrimer polycation coupled to the polynucleotide |
| 11/23/1999 | US5989918 ADME analysis of mixtures |
| 11/23/1999 | US5989630 Polymers having more than one void |
| 11/23/1999 | US5989591 Dosage unit containing poloxamer and sucrose overcoat |
| 11/23/1999 | US5989590 Oral delivery of discrete units |
| 11/23/1999 | US5989589 Cross-linked cellulose as a tablet excipient |
| 11/23/1999 | US5989586 Two-phase matrix for sustained release drug delivery device |
| 11/23/1999 | US5989585 Transdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependency |
| 11/23/1999 | US5989583 Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability |
| 11/23/1999 | US5989581 Thermoplastic polymer core and skin containing steroidal progestogenic compound and steroidal estrogenic compound |
| 11/23/1999 | US5989580 Delivering biocompatible polymer, contrast agent and solvent to fallopian tubes, precipitating polymer to sterilize female |
| 11/23/1999 | US5989579 Ocular insert with anchoring protrusions |
| 11/23/1999 | US5989577 Nontoxic vernix compositions and method of producing |
| 11/23/1999 | US5989571 Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory |
| 11/23/1999 | US5989567 Method and device for infant male circumcision anesthesia |
| 11/23/1999 | US5989566 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation |
| 11/23/1999 | US5989558 Extracting leaves with aqueous ethanol |
| 11/23/1999 | US5989557 Process for extracting polyphenol fractions of tea and compositions produced therewith |
| 11/23/1999 | US5989556 Compositions of matter useful in the treatment of viral infections derived from plant extracts |
| 11/23/1999 | US5989539 Compounds and compositions for delivering active agents |
| 11/23/1999 | US5989536 Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
| 11/23/1999 | US5989535 Polymeric bioadhesive emulsions and suspensions and methods of treatment |
| 11/23/1999 | US5989523 Topical spray for treating acne containing niacinamide and NaPCA |
| 11/23/1999 | US5989522 Anti-mycotic drug and ethyl cellulose to provide sustained release |
| 11/23/1999 | US5989521 Method for augmenting a decreased level of reduced glutathione in the lung |
| 11/23/1999 | US5989520 Biotinylated lipid coated emulsion containing a paramagnetic element and a fluorochemical |
| 11/23/1999 | US5989463 Methods for fabricating polymer-based controlled release devices |
| 11/23/1999 | US5989217 Medicine administering device for nasal cavities |
| 11/23/1999 | US5988870 Apparatus and method for diluting nasal sprays containing addictive compounds |
| 11/23/1999 | CA2176206C Harmonic ultrasound imaging with microbubbles |
| 11/23/1999 | CA2148109C 1.alpha., 24-(oh)2-v.d.3 emulsion composition |
| 11/23/1999 | CA2129254C Improved method for manufacturing freeze dried dosages in a multilaminate blister pack |
| 11/23/1999 | CA2103680C Improved blood substitute |
| 11/23/1999 | CA2074309C Stabilized controlled release formulations having acrylic polymer coating |
| 11/23/1999 | CA2070706C Pulverulent products composed of a water-insoluble core substance and of a protective covering |
| 11/23/1999 | CA2015919C Cleaning compositions |
| 11/23/1999 | CA2006184C Prolonged release composition based on trimebutine and process for the preparation thereof |
| 11/23/1999 | CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments |
| 11/18/1999 | WO1999058694A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 11/18/1999 | WO1999058575A1 Aloe pectins |
| 11/18/1999 | WO1999058555A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
| 11/18/1999 | WO1999058504A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 11/18/1999 | WO1999058503A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments |
| 11/18/1999 | WO1999058132A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 11/18/1999 | WO1999058131A1 Use of tetracyclines for treating meibomian gland disease |
| 11/18/1999 | WO1999058129A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
| 11/18/1999 | WO1999058116A2 Novel formulation containing paroxetine |
| 11/18/1999 | WO1999058115A1 Antidepressant therapy |
| 11/18/1999 | WO1999058114A1 Sustained release tablets, additive compositions therefor and process for producing the same |
| 11/18/1999 | WO1999058113A2 Novel formulation containing paroxetine |
| 11/18/1999 | WO1999058112A1 Improvements relating to encapsulation of bioactive agents |
| 11/18/1999 | WO1999058111A1 Methods of using lipid based drug delivery vehicles |
| 11/18/1999 | WO1999058110A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 11/18/1999 | WO1999058109A1 Biologically active composition |
| 11/18/1999 | WO1999058108A1 Biologically active composition |
| 11/18/1999 | WO1999058107A2 Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use |
| 11/18/1999 | WO1999058089A1 Laminate for application onto an acceptor |
| 11/18/1999 | WO1999057995A1 Use of 'nanofood' in foodstuff final products for humans and animals |
| 11/18/1999 | WO1999051271A3 Compositions comprising glycol derivatives and alcohols |